Ohio State Navbar

Our Team

Douglas Martin, MD


 

 

Clinical Director, Radiation Oncology
Associate Professor, Radiation Oncology
Department Quality Committee Chair

 

 

 

 


Committee Memberships

National

  • 2010-Present: Radiation Oncology Committee Member, Gynecologic Oncology Group – NRG (committee in transition)
  • 2012-Present: Cervix Committee Member, NRG
  • 2012-Present: American College of Radiology Surveyor in Radiation Oncology

Local

  • Present: Vice Chair, University Radiation Safety Commitee
  • Present: University Radiation Safety Committee and Medical Use Subcommittee
  • Present: OSUMC credentials committee
  • Present: OSUMC IHIS Physician Advisory Committee
  • Present: OSUMC Crew Resource Management Steering Committee
  • Present: Transition team member, new James Cancer Hospital
  • Present: OSUP Physician Productivity subcommittee
  • Present: Nationwide Children’s Hospital Cancer Committee
  • 2007-Present: James Cancer Hospital Disease Site Committee member for: Sarcoma Disease Committee, Genitourinary Malignancies and Gynecologic Cancers.
  • 2009-Present: OSU Medical School Learning Community Leader
  • 2006-Present: Associate Investigator - Radiation Therapy Oncology & Gynecologic Oncology Group, Ohio State University Medical Center.
  • 1997-2002, 2009-Present: Associate Investigator – Children’s Oncology Group, Ohio State University Medical Center and Nationwide Children’s Hospital

 Publications

  • Quick AM, Seamon LG, Abdel-Rasoul M, Salani R, Martin D. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma. Int J Gynecol Cancer. 2012 May;22(4):703-8.
  • Martin, D, “REVIEW OF RADIATION THERAPY IN THE PREGNANT CANCER PATIENT”, Clin Obstet Gynecol. 2011 Dec;54(4):591-601.
  • Martin, D and Bahnson, R, “LOW DOSE RATE PROSTATE BRACHYTHERAPY 1915-2011” AUA News, July 2011.
  • Zhang H, Martin D, Chiu-Tsao ST, Meigooni A, Thomadsen BR. “A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.” Brachytherapy, v. 9 issue 4, 2010, p. 362-72.
  • Korytko, T, Lowe, G, Jimenez, R, Pohar, K, Martin, D. Prostate Specific Antigen Response. After Definitive Radiotherapy for Skene's Gland Adenocarcinoma Resembling Prostate Adenocarcinoma. Urol Oncol. 2010 Sep 24. [Epub ahead of print]
  • Richardson DL, Seamon LG, Resnick KE, Martin D, Fowler JM. Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy. Gynecol Oncol. 2009 Nov;115(2):306-7. Epub 2009 Jul 3. PubMed PMID: 19576621.
  • Zhang H, Wang JZ, Mayr N, Kong X, Yuan J, Gupta N, Lo S, Grecula J, Montebello J, Martin D, Yuh W. Fractionated grid therapy in treating cervical cancers: conventional fractionation or hypofractionation? Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):280-8.
  • Martin, D. Is there a role for radical surgery in cT3a prostate cancer? Results from a single institution and single surgeon over 17 years. Review article. Am J Hematology/Oncology. Aug 2007, Vol 6, No 8.
  • Mayr NA, Lo SS, Grecula J, Wang J, Zhang H, Montebello J, Martin D, Yuh WT. Tumor imaging: radiation oncology perspective. Top Magn Reson Imaging. 2006 Apr;17(2):117-9. Review.
  • Johnstone PA, Riffenburgh RH, Moul JW, Sun L, Wu H, McLeod DG, Kane CJ, Martin DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley J, Chung A, Soderdahl D, Do J, Amling CL; Department of Defense Center for Prostate Disease Research. Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):964-9.
  • Johnston, PA; Kane, CJ; Sun, L; Wu, H; Moul, JW; McLeod, DG; Martin, DD; Kusuda, L; Lance, R; Douglas, R; Donahue, T; Beat, MG; Foley, J; Baldwin, D; Soderdahl, D; Do, J; Amling, CL; “Effect of Race on Biochemical Disease-Free Outcome in Patients with Prostate Cancer Treated with Definitive Radiation Therapy in an Equal-Access health Care System: Radiation Oncology Report of the Department of Defense Center for Prostate Disease Research”, Radiology, November; 225 (2): 420-6, 2002.
  • Buchholz, TA; Eng, TY; Martin, DD; Powell, CR; Johnstone, PAS; Allen, P; “Do Calcium Channel Blockers Adversely Affect Hormonal Treatment of Prostate Cancer through and Inhibition of Apoptosis?”, The Prostate Journal, Vol. 1, No. 1, 43-48, 1999.
  • Mayr, NA; Yuh, WTC; Magnotta, VA; Ehrhardt, JC; Wheeler, JA; Sorosky, JI; Davis, CS; Wen, BC; Martin, DD; et al, “Tumor Perfusion Studies Using Fast Magnetic Resonance Imaging Technique in Advanced Cervical Cancer: A New Noninvasive Predictive Assay”, IJROBP, Vol. 36, No. 3, 623-633, 1996.
  • Martin, DD; Robbins, MEC; Spector, AA; Wen, BC; Hussey, DH; “The Fatty Acid Composition of Human Malignant Glioma Tumors Differs from that found in Non-Malignant Brain Tissue”, Lipids, Vol. 31, No. 12, 1283-1288, 1996.